Canaccord Genuity Released a Comprehensive Research Report on MindMed Complete a with Bullish Buy Rating and Price Target The Leading Psychedelic Drug Development Company Also Submitted an Application to Uplist... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of September 14th – 20th, 2020.... read more →
The psychedelics business is developing faster now than ever before, kicked off in earnest when the FDA granted a “breakthrough therapy” designation to Compass Pathways in October 2018 and has... read more →
With the global pandemic still raging on, becoming a divisive issue in the U.S. and other countries for a variety of reasons, everyone is looking for real science-based answers to... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of September 7th - 13th, 2020.... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of September 7th - 13th, 2020.... read more →
In Yet Another Sign That Psychedelics Are Making Their Way Into the Mainstream, Compass Pathways, a UK-Based Psychedelics Startup Focused on Producing Psilocybin, Has Filed for its Initial Public Offering... read more →
Efforts to Legalize Psilocybin Just Took a Huge Step Forward Because of an Initiative on the Ballot for Oregon Voters to Consider This November—Oregon Measure 109, the Psilocybin Program Initiative... read more →
A Few Months Ago, Mike Tyson Made Headlines After Announcing Plans to Expand His Cannabis-Themed Tyson Ranch The Former Heavyweight Champ is Back in the News Following Recent Comments Made... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of August 31st - September 6th,... read more →
